Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population

Published:2013-12-09 Issue:5 Volume:164 Page:684-693
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Liwing Johan¹,Uttervall Katarina¹,Lund Johan¹,Aldrin Anders²,Blimark Cecilie³,Carlson Kristina⁴,Enestig Jon⁵,Flogegård Max⁶,Forsberg Karin⁷,Gruber Astrid¹,Haglöf Kviele Helene⁴,Johansson Peter⁸,Lauri Birgitta⁹,Mellqvist Ulf-Henrik³,Swedin Agneta¹⁰,Svensson Magnus¹¹,Näsman Per¹²,Alici Evren¹,Gahrton Gösta¹,Aschan Johan¹³,Nahi Hareth¹

Affiliation:

1. Department of Medicine; Karolinska Institutet; Stockholm Sweden

2. Internal Medicine; Visby Hospital; Visby Sweden

3. Sahlgrenska University Hospital; Gothenburg Sweden

4. Department of Haematology; Uppsala University Hospital; Uppsala Sweden

5. Internal Medicine; Capio S:t Göran Hospital; Stockholm Sweden

6. Internal Medicine; Falun Hospital; Falun Sweden

7. Norrlands University Hospital; Umeå Sweden

8. Uddevalla Hospital; Uddevalla Sweden

9. Internal Medicine; Sunderby Hospital; Luleå Sweden

10. Haematology; Skåne University Hospital; Lund Sweden

11. Internal Medicine; Mälarsjukhuset; Eskilstuna Sweden

12. Centre for Safety Research; Royal Institute of Technology KTH; Stockholm Sweden

13. Medical Affairs; Janssen-Cilag AB; Sollentuna Sweden

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12685/fullpdf

Reference27 articles.

1. Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3;Barlogie;British Journal of Haematology,2007

2. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up;Bjorkstrand;Journal of Clinical Oncology,2011

3. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant;Blade;British Journal of Haematology,1998

4. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study;Cavo;Lancet,2010

5. Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT;Crawley;Blood,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma;Frontiers in Oncology;2023-11-02

2. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: Methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies;Clinical Chemistry and Laboratory Medicine (CCLM);2023-07-04

3. Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma;Cancers;2023-03-02

4. Conditioning with melphalan 200 mg/m ² and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care;European Journal of Haematology;2022-09-20

5. REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3